Targeting Tumour-Initiating Cells with TRAIL Based Combination Therapy Ensures Complete and Lasting Eradication of Multiple Myeloma Tumours In Vivo

le Vitovski, Srdjan, Chantry, Andrew D., Lawson, Michelle A., Croucher, Peter I.
Foilsithe 2012

New agents in the Treatment of Myeloma Bone Disease

le Ring, Elizabeth S., Lawson, Michelle A., Snowden, John A., Jolley, Ingrid, Chantry, Andrew D.
Foilsithe in Calcif Tissue Int (2017)

ARQ-197, a small-molecule inhibitor of c-Met, reduces tumour burden and prevents myeloma-induced bone disease in vivo

le Lath, Darren L., Buckle, Clive H., Evans, Holly R., Fisher, Matthew, Down, Jenny M., Lawson, Michelle A., Chantry, Andrew D.
Foilsithe in PLoS One (2018)

JZL184, A Monoacylglycerol Lipase Inhibitor, Induces Bone Loss in a Multiple Myeloma Model of Immunocompetent Mice

le Marino, Silvia, Carrasco, Giovana, Li, Boya, Shah, Karan M., Lath, Darren L., Sophocleous, Antonia, Lawson, Michelle A., Idris, Aymen I.
Foilsithe in Calcif Tissue Int (2020)

NOD/SCID-GAMMA Mice Are an Ideal Strain to Assess the Efficacy of Therapeutic Agents Used in the Treatment of Myeloma Bone Disease

le Lawson, Michelle A., Paton-Hough, Julia M., Evans, Holly R., Walker, Rebecca E., Harris, William, Ratnabalan, Dharshi, Snowden, John A., Chantry, Andrew D.
Foilsithe in PLoS One (2015)

Preventing and Repairing Myeloma Bone Disease by Combining Conventional Antiresorptive Treatment With a Bone Anabolic Agent in Murine Models

le Paton‐Hough, Julia, Tazzyman, Simon, Evans, Holly, Lath, Darren, Down, Jenny M, Green, Alanna C, Snowden, John A, Chantry, Andrew D, Lawson, Michelle A
Foilsithe in J Bone Miner Res (2018)

Differential Pain‐Related Behaviors and Bone Disease in Immunocompetent Mouse Models of Myeloma

le Diaz‐delCastillo, Marta, Kamstrup, Danna, Olsen, Rikke Brix, Hansen, Rie Bager, Pembridge, Thomas, Simanskaite, Brigita, Jimenez‐Andrade, Juan Miguel, Lawson, Michelle A, Heegaard, Anne‐Marie
Foilsithe in JBMR Plus (2019)

Low-dose methotrexate in myeloproliferative neoplasm models

le Chinnaiya, Kavitha, Lawson, Michelle A., Thomas, Sally, Haider, Marie-Therese, Down, Jenny, Chantry, Andrew D., Hughes, David, Green, Antony, Sayers, Jon R., Snowden, John A., Zeidler, Martin P.
Foilsithe in Haematologica (2017)

Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts

le Bassett, J. H. Duncan, Boyde, Alan, Howell, Peter G. T., Bassett, Richard H., Galliford, Thomas M., Archanco, Marta, Evans, Holly, Lawson, Michelle A., Croucher, Peter, St. Germain, Donald L., Galton, Valerie Anne, Williams, Graham R.
Foilsithe 2010

The E3 ligase HUWE1 inhibition as a therapeutic strategy to target MYC in multiple myeloma

le Crawford, Lisa J., Campbell, David C., Morgan, Jonathan J., Lawson, Michelle A., Down, Jennifer M., Chauhan, Dharminder, McAvera, Roisin M., Morris, Treen C., Hamilton, Claudia, Krishnan, Aswini, Rajalingam, Krishnaraj, Chantry, Andrew D., Irvine, Alexandra E.
Foilsithe in Oncogene (2020)

The Pharmacological Profile of a Novel Highly Potent Bisphosphonate, OX14 (1‐Fluoro‐2‐(Imidazo‐[1,2‐α]Pyridin‐3‐yl)‐Ethyl‐Bisphosphonate)

le Lawson, Michelle A, Ebetino, Frank H, Mazur, Adam, Chantry, Andrew D, Paton‐Hough, Julia, Evans, Holly R, Lath, Darren, Tsoumpra, Maria K, Lundy, Mark W, Dobson, Roy LM, Quijano, Michael, Kwaasi, Aaron A, Dunford, James E, Duan, Xuchen, Triffitt, James T, Jeans, Gwyn, Russell, R Graham G
Foilsithe in J Bone Miner Res (2017)

Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche

le Lawson, Michelle A., McDonald, Michelle M., Kovacic, Natasa, Hua Khoo, Weng, Terry, Rachael L., Down, Jenny, Kaplan, Warren, Paton-Hough, Julia, Fellows, Clair, Pettitt, Jessica A., Neil Dear, T., Van Valckenborgh, Els, Baldock, Paul A., Rogers, Michael J., Eaton, Colby L., Vanderkerken, Karin, Pettit, Allison R., Quinn, Julian M. W., Zannettino, Andrew C. W., Phan, Tri Giang, Croucher, Peter I.
Foilsithe in Nat Commun (2015)